BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2935151)

  • 1. Serotonin-S2 and dopamine-D2 receptors are the same size in membranes.
    Brann MR
    Biochem Biophys Res Commun; 1985 Dec; 133(3):1181-6. PubMed ID: 2935151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB
    Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
    Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS; Dakshinamurti K
    J Neurosci Res; 1985; 14(2):263-70. PubMed ID: 4046074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.
    Altar CA; Wasley AM; Neale RF; Stone GA
    Brain Res Bull; 1986 Apr; 16(4):517-25. PubMed ID: 2872945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.
    McGonigle P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S73-7. PubMed ID: 2459520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade.
    Leysen JE; Van Gompel P; de Chaffoy de Courcelles D; Niemegeers CJ
    J Recept Res; 1987; 7(1-4):223-39. PubMed ID: 3625598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM; Janssen PF; Leysen JE
    Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target size analysis of serotonin 5-HT1 and 5-HT2 receptors in bovine brain membranes.
    Nishino N; Tanaka C
    Life Sci; 1985 Sep; 37(12):1167-74. PubMed ID: 3162074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK; Maloteaux JM; Laduron PM
    J Neurochem; 1984 Oct; 43(4):1068-71. PubMed ID: 6088690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarine-binding sites localized to cortical dopamine terminals.
    Liskowsky DR; Potter LT
    Neurosci Lett; 1985 Jul; 58(2):229-33. PubMed ID: 2931625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2 dopamine receptors in the rat prefrontal cortex: characterization and alteration by stress.
    MacLennan AJ; Pelleymounter MA; Atmadja S; Jakubovic A; Maier SF; Fibiger HC
    Brain Res; 1989 Jan; 477(1-2):300-7. PubMed ID: 2522809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats.
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):665-8. PubMed ID: 6531438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex.
    Lyon RA; Titeler M; Frost JJ; Whitehouse PJ; Wong DF; Wagner HN; Dannals RF; Links JM; Kuhar MJ
    J Neurosci; 1986 Oct; 6(10):2941-9. PubMed ID: 2944994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.